ADIPOQ and type 2 diabetes mellitus: In addition, chronic systemic inflammation is recognized as part of insulin resistance syndrome, T2DM, and obesity and is characterized by increased IL-6 and CRP levels, as well as decreased levels of adiponectin (ADIPOQ) and IL-10 [16].